Stocks › ARGX

ARGENX SE

ARGX·Nasdaq·USD
$925.70
-16.34 (-1.73%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
ARGX
ARGENX SE · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ARGXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of ARGX by members of U.S. Congress · 5 on record · 4 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA ARGXARGENX SE · Stock Purchase
$1,001 - $15,000
Nov 10, 2026 Oct 15, 2026 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA ARGXARGENX SE · Stock Purchase
$15,001 - $50,000
Nov 10, 2026 Oct 14, 2026 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA ARGXARGENX SE · Stock Purchase
$1,001 - $15,000
Nov 10, 2026 Oct 27, 2026 Filing ↗
Alan ArmstrongAlan ArmstrongSenate · R · OK ARGXARGENX SE · Stock Purchase
$1,001 - $15,000
Jul 21, 2026 Mar 30, 2026 Filing ↗
Daniel S. GoldmanDaniel S. GoldmanHouse · D · NY ARGXARGENX SE · Stock Sale
$1,001 - $15,000
Aug 13, 2023 Jul 10, 2023 Filing ↗

Whale Activity

Position changes in ARGX reported for 2026-09-30 by 599 institutional filers
Increased: 215New: 89Held: 83Decreased: 139Closed: 46No prior filing: 27
  • Increased215
  • New89
  • Held83
  • Decreased139
  • Closed46
  • No prior filing27
FilerSharesValueChange
FMR LLC5.4M$5.14Bincreased
Janus Henderson Group Ltd.2.4M$2.29B—
Capital World Investors2.3M$2.19Bincreased
PRICE T ROWE ASSOCIATES INC /MD/2.2M$2.15Bdecreased
Artisan Partners Limited Partnership1.2M$1.12Bdecreased
Avoro Capital Advisors LLC1.0M$958.9Mheld
BlackRock, Inc.879.3K$843.1Mincreased
WELLINGTON MANAGEMENT GROUP LLP715.9K$686.5Mdecreased
RTW INVESTMENTS, LP711.6K$682.3Mincreased
MORGAN STANLEY586.5K$562.4Mdecreased
CITADEL ADVISORS LLC500.1K$479.5Mincreased
BANK OF AMERICA CORP /DE/468.5K$449.3Mincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by ARGX insiders, by quarter · Form 4

No open-market insider buys or sells in the last two years.

Recent Insider Transactions

0 transactions on record · newest first
All insider activity →

No insider transactions on record.

Fund Holders

Mutual funds and ETFs holding ARGX · SEC Form N-PORT
FundSharesValue% of fundAs of
EUPAC Fund1.0M$950.3M0.67%Jun 30, 2026
New Economy Fund775.3K$799.8M1.60%Aug 31, 2026
Fidelity Growth Company Fund
Fidelity Mt. Vernon Street Trust
608.3K$627.6M0.64%Aug 31, 2026
Janus Henderson Forty Fund
Janus Investment Fund
519.0K$481.5M2.02%Jun 30, 2026
Fidelity OTC Portfolio
Fidelity Securities Fund
481.9K$411.5M0.95%Jul 31, 2026
iShares Biotechnology ETF
iShares Trust
368.2K$341.6M3.76%Jun 30, 2026
Janus Henderson Enterprise Fund
Janus Investment Fund
309.1K$286.7M1.28%Jun 30, 2026
T. Rowe Price Growth Stock Fund, Inc.225.0K$208.8M0.42%Jun 30, 2026
T. Rowe Price Large-Cap Growth Fund
T. Rowe Price Equity Funds, Inc.
211.4K$196.1M0.95%Jun 30, 2026
Fidelity Contrafund210.5K$195.3M0.11%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list ARGX's shares (CUSIP 04016X101), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 6.2M shares9.9%
    Nov 5, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 6.2M shares9.9%
    Nov 5, 2026 · ↗
  • T. Rowe Price Associates, Inc.SCHEDULE 13G/A · passive (13G) · 2.7M shares4.3%
    Aug 14, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 5.4M shares8.7%
    May 6, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 5.4M shares8.7%
    May 6, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming ARGENX SE as client

No lobbying filings found naming ARGENX SE as the client.

Government Contracts

Federal awards to ARGENX SE · USAspending

No federal contract awards found for ARGENX SE.

U.S. Patents

Recent USPTO applications naming ARGENX SE

No USPTO patent applications found for ARGENX SE.

Annual Financials

From ARGX's 10-K filings · XBRL

SEC's XBRL figures for ARGENX SE include no full-year results from a 10-K in US dollars, so there is no table to show. Companies based abroad usually report annually on Form 20-F instead.

Stock Splits

Every split and reverse split in the price history

No stock splits in ARGX's price history.

Material Events (8-K)

Corporate events filed with the SEC

No 8-K filings on record.

About ARGENX SE

From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersZWIJNAARDE
IncorporatedP7
Former namesargenx N.V